Publication | Closed Access

The enhanced value of combining conventional and “omics” analyses in early assessment of drug-induced hepatobiliary injury

HepatologyPreclinical Drug EvaluationMedicineLiver PhysiologyLaboratory MedicineDrug-induced Hepatobiliary InjuryDrug Monitoring“ OmicsEarly AssessmentHepatotoxicityLiver DiseasePharmacologyDrug-induced Liver Injury